This is the first domestically produced sterilized glass vial (nest packaging) with all manufacturing processes conducted in Japan.
In order to achieve the compactification of the formulation manufacturing line and cost reduction, we have developed TasPack-TD® in collaboration with Daisei Chemical Co., Ltd. This product undergoes washing with Water for Injection (WFI), depyrogenation treatment, and EOG (ethylene oxide gas) sterilization at Daisei Chemical Co., Ltd. after bottle molding at our company. Since all manufacturing processes are conducted domestically in Japan, it is less susceptible to the impacts of international situations, ensuring stable supply and significantly reduced lead times. 【Features】 ■ RTU (Ready To Use) specification allows for immediate filling ■ Sterilization guarantee of containers (SAL=10⁻⁶) reduces the burden of quality operations ■ All vials are low-alkali and comply with three pharmacopoeias (USP, EP, JP), among others *For more details, please refer to the catalog or feel free to contact us.
Inquire About This Product
basic information
For more details, please refer to the catalog or feel free to contact us.
Price range
Delivery Time
※Please feel free to contact us.
Applications/Examples of results
We have a track record of adoption in companies without sterilization equipment, as well as in research institutions and laboratories in regenerative medicine.
Detailed information
-
Tab nest type
-
Tray type (ISO10R size only)
Line up（1）
| Model number | overview |
|---|---|
| ISO2R, 10R size | Other sizes will be prepared sequentially. |
catalog（1）
Download All Catalogs
Company information
Our company was established in 1942 as a glass ampoule manufacturing company. Since then, we have consistently focused on the pharmaceutical-related industry, which is directly linked to human life and health, with container supply as the core of our business. We are the leading domestic company in the manufacturing of glass vials for pharmaceuticals, and particularly in the case of glass vials for vaccines, we hold a 30% market share, making us the top company in the country. We will continue to contribute to human life and health with next-generation pharmaceutical containers, such as our low-leaching vials (VIST) developed through our unique technology.
